KZA 0.00% 8.0¢ kazia therapeutics limited

SNO 26th Annual Meeting, page-71

  1. 1,148 Posts.
    lightbulb Created with Sketch. 819
    EXTH-62. COMBINATIONAL THEARAPY TARGETING TRANSCRIPTION AND IMMUNO - METABOLISM IN RECURRENT GLIOBLASTOMA.

    Exciting times ahead for Kazia over the next few years, happy days!
    Posted by Rene Schueler @ Rinnekin disallowed

    https://hotcopper.com.au/data/attachments/3790/3790068-3a7b62f6cb3babab553657e2d9b57c55.jpg
    Regards.


 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.